Please assess the completion status of the following clinical trial:

Trial Title: Therapeutic Oxygen for Gastrointestinal Atony (TOGA)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* patient or health proxy has been adequately informed of risks and benefits and agrees to his/her participation in the study.~* patient is a hospitalized inpatient diagnosed with ileus, bowel obstruction or colonic pseudo-obstruction \[clinician interpretation or small bowel diameter ≥3.5 cm, cecal diameter ≥ 9 cm, sigmoid colon diameter ≥ 6 cm\].~* patient is clinically and hemodynamically stable~* patient does not require supplemental oxygen greater than 2 liters per minute via nasal cannula~* patient does not have any respiratory contraindications to 100% oxygen~* failure to respond to non-surgical/non-endoscopic therapy for at least 24 hours, therapy at discretion of treating physician \[to eliminate patients with trivial ileus not requiring advanced intervention\]~Exclusion Criteria:~* patient is not expected to survive in the short term.~* patient is a pregnant or lactating woman.~* patient presents with severe or unstable psychiatric disorders.~* patient is participating in concomitant research studies that would interfere with this study.~* patient is an alcohol or drug abuser.~* respirator support required.~* unable to tolerate 100% oxygen for respiratory reasons or any other reasons.~* perforation of the viscus.~* inability to obtain informed consent.~* hypoxemia, as in room air oxygen saturation less than 90%.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Hospitalized Ileus or Pseudo-Obstruction Patient (Type: EXPERIMENTAL): Hospitalized inpatient diagnosed with ileus, bowel obstruction or colonic pseudo-obstruction \[clinician interpretation or small bowel diameter ≥3.5 cm, cecal diameter ≥ 9 cm, sigmoid colon diameter ≥ 6 cm\] provided with 100% oxygen via non-rebreather face mask, for 6 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).